February
2003
Molecular Imaging
At Massachusetts General
Hospital's Center for Molecular Imaging Research-a bustling facility nestled
next to an old Navy shipyard-Umar Mahmood uses a digital camera to peer through
the skin of a living mouse into a growing tumor. Using fluorescent tags and
calibrated filters, the radiologist actually sees the effects of the cancer on a molecular
scale: destructive enzymes secreted by the tumor show up on Mahmood's computer
screen as splotches of red, yellow, and green. In the future, he says, such
"molecular imaging" may lead to earlier detection of human disease,
as well as more effective therapies.
Molecular
imaging-shorthand for a number of techniques that let researchers watch genes,
proteins, and other molecules at work in the body-has exploded, thanks to
advances in cell biology, biochemical agents, and computer analysis. Research
groups around the world are joining the effort to use magnetic, nuclear, and
optical imaging techniques to study the molecular interactions that underlie
biological processes. Unlike x-ray, ultrasound, and other conventional
techniques that give doctors only such anatomical clues as the size of a tumor,
molecular imaging could help track the underlying causes of
disease. The appearance of an unusual protein in a cluster of cells, say, might
signal the onset of cancer. Mahmood is helping to lead the effort to put the
technology into medical practice.
It is challenging,
though, to detect a particular molecule in the midst of cellular activity. When
researchers inject a tag that binds to the molecule, they face the problem of
distinguishing the bound tags from the extra, unbound tags. So Mahmood has
worked with chemists to develop "smart probes" that change their
brightness or their magnetic properties when they meet their target. "This
is a big deal," says David Piwnica-Worms, director of the Molecular
Imaging Center at Washington University in St. Louis. The method, he explains,
"allows you to see selected proteins and enzymes that you might miss with
standard tracer techniques."
In a series of
groundbreaking experiments, Mahmood's team treated cancerous mice with a drug
meant to block the production of an enzyme that promotes tumor growth. The
researchers then injected fluorescent probes designed to light up in the
presence of that enzyme. Under an optical scanner, treated tumors showed up as
less fluorescent than untreated tumors, demonstrating the potential of
molecular imaging to monitor treatments in real time-rather than waiting months
to see whether a tumor shrinks. "The big goal is to select the optimum
therapy for a patient and then to check that, say, a drug is hitting a
particular receptor," says John Hoffman, director of the Molecular Imaging
Program at the National Cancer Institute. What's more, molecular imaging could
be used to detect cancer signals that precede anatomical changes by months or
years, eliminating the need for surgeons to cut out a piece of tissue to make a
diagnosis. "At the end of the day, we may replace a number of biopsies
with imaging," Mahmood says.
In Mahmood's lab,
clinical trials are under way for magnetic resonance imaging of blood vessel
growth-an early indicator of tumor growth and other changes. For more advanced
techniques such as those used in the mouse cancer study, clinical trials are
two years away. The big picture: 10 years down the road, molecular imaging may
take the place of mammograms, biopsies, and other diagnostic techniques.
Although it won't replace conventional imaging entirely, says Mahmood,
molecular imaging will have a profound effect both on basic medical research
and on high-end patient care. Indeed, as his work next door to the shipyard
makes clear, an important new field of biotechnology has set sail. -Gregory T. Huang
Others in
MOLECULAR IMAGING RESEARCHER PROJECT Ronald Blasberg
Memorial Sloan-Kettering Cancer Center Imaging of gene expression Harvey Herschman
U. California, Los Angeles Tracking of gene therapy, gene activities David Piwnica-Worms
Washington U. Protein interactions, imaging tools Patricia Price
U. Manchester Clinical oncology, imaging drug targets Ralph Weissleder
Harvard Medical School Cell tracking, molecular targets, drug discovery
MOLECULAR IMAGING RESEARCHER PROJECT Ronald Blasberg
Memorial Sloan-Kettering Cancer Center Imaging of gene expression Harvey Herschman
U. California, Los Angeles Tracking of gene therapy, gene activities David Piwnica-Worms
Washington U. Protein interactions, imaging tools Patricia Price
U. Manchester Clinical oncology, imaging drug targets Ralph Weissleder
Harvard Medical School Cell tracking, molecular targets, drug discovery
No comments:
Post a Comment